FINWISE BANCORP FINW 深 沪
已收盘 08-29 16:00:00 美东时间
19.33
-0.140
-0.72%
华盛通- 最 高19.70
- 今 开19.63
- 成交量 7516股
- 最 低 19.28
- 昨 收 19.47
- 总市值 2.55亿
- 52周最高 20.94
- 市盈率 静 20.70
- 换手率 0.06%
- 52周最低 13.17
- 委 比 -78.57%
- 总股本 1321.48万
- 历史最高 21.86
- 量 比 0.37
- 振 幅 2.16%
- 历史最低 7.61
- 每 手 1
- 风险率 2.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For July 24, 2025
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is likely to repo...
07-24 16:32
Insights Ahead: FinWise's Quarterly Earnings
FinWise (NASDAQ:FINW) is set to give its latest quarterly earnings report on Th...
07-24 05:02
FinWise Bancorp to be added to Russell 2000 index
FinWise Bancorp (NASDAQ:FINW) said it has been added as a member of the U.S. small-cap Russell 2000 index. The addition will be effective after the U.S. market opens on June 30 as part of the 2025 Rus...
05-27 20:20
FinWise Bancorp Added to Membership of US Small-Cap Russell 2000® Index
FinWise Bancorp has been added to the Russell 2000® Index effective June 30, 2025, as part of the 2025 Russell indexes reconstitution. The company, a parent of FinWise Bank, specializes in Banking and Payments solutions for fintech brands and provides various lending programs. Membership in the Russell 2000® Index is based on inclusion in the broader Russell 3000® Index and lasts for one year. The stock also joins relevant growth and value indexe...
05-27 11:30
FinWise Bancorp outlines $50M-$100M credit enhanced balance growth for 2025
Earnings Call Insights: FinWise Bancorp (FINW) Q1 2025 Management View CEO Kent Landvatter highlighted the resilience of FinWise Bancorp amid macroeconomic challenges, reporting $1.3 billion in loan o...
05-01 09:05
美股大行评级 | 潜在涨幅684.71%！Verve Therapeutics获Canaccord Genuity升目标价至39美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1119185980869894144.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Verve Therapeutics(VERV)"买入"评级，目标价从32美元升至39美元</p> <p>• HC Wainwright & Co.：维持Verve Ther
04-16 09:45
美股大行评级 | 潜在涨幅506.8%！HC Wainwright & Co.上调Verve Therapeutics目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1118823510909566976.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Verve Therapeutics(VERV)"买入"评级，目标价从15美元升至25美元</p> <p>• Piper Sandler：维持LENZ Therapeut
04-15 11:35
Big banks’ bullish reversals – top SA Quant-rated U.S. banks
Big banks (BKX) are seeing a bullish reversal. Banks (KRE), (KBE), (KBWB) are coming off their supports from their 50-week levels and now experiencing “bullish reversals,” said Rich Ross, head of tech...
03-18 03:09
Stock selloff slashes needed-market cap for new Russell 2000 additions: Stephens
The market capitalization needed for companies to join the Russell 2000 Index (RTY) this year has nosedived as stocks have tumbled, according to investment advisory firm Stephens. New additions to th...
03-13 20:00
